• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Extra-renal manifestations of atypical hemolytic uremic syndrome.非肾性表现的非典型溶血尿毒综合征。
Pediatr Nephrol. 2019 Aug;34(8):1337-1348. doi: 10.1007/s00467-018-4039-7. Epub 2018 Aug 14.
2
Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.儿童非典型溶血尿毒综合征的肾外表现。
Pediatr Nephrol. 2018 Aug;33(8):1395-1403. doi: 10.1007/s00467-018-3933-3. Epub 2018 Apr 2.
3
Macrovascular involvement in a child with atypical hemolytic uremic syndrome.一名患有非典型溶血尿毒综合征儿童的大血管受累情况。
Pediatr Nephrol. 2014 Jul;29(7):1273-7. doi: 10.1007/s00467-013-2713-3. Epub 2013 Dec 19.
4
The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome.补体替代途径与非典型溶血尿毒综合征不断演变的临床病理生理谱
Am J Med Sci. 2016 Aug;352(2):177-90. doi: 10.1016/j.amjms.2016.05.003. Epub 2016 May 9.
5
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.非典型溶血尿毒综合征:病理生理学、诊断及治疗的最新进展
Ther Apher Dial. 2019 Feb;23(1):4-21. doi: 10.1111/1744-9987.12763. Epub 2018 Oct 29.
6
Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.产后伴有肾脏受累的非典型溶血尿毒综合征患者补体替代途径的过度激活。
Am J Reprod Immunol. 2015 Oct;74(4):345-56. doi: 10.1111/aji.12404. Epub 2015 May 24.
7
A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.妊娠相关性非典型溶血尿毒综合征/补体介导的血栓性微血管病的病例叙述性综述。
Kidney Int. 2024 May;105(5):960-970. doi: 10.1016/j.kint.2023.12.021. Epub 2024 Feb 24.
8
Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.妊娠合并非典型溶血尿毒综合征患者的母婴结局。
J Am Soc Nephrol. 2018 Mar;29(3):1020-1029. doi: 10.1681/ASN.2016090995. Epub 2017 Dec 27.
9
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.非典型溶血尿毒综合征患者孤立性小肠血栓性微血管病 - 病例报告。
BMC Nephrol. 2020 Mar 24;21(1):104. doi: 10.1186/s12882-020-01766-0.
10
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.在一项长期观察性研究中,用依库珠单抗治疗非典型溶血尿毒综合征患者的结果。
BMC Nephrol. 2019 Apr 10;20(1):125. doi: 10.1186/s12882-019-1314-1.

引用本文的文献

1
Demographics and baseline disease characteristics of UK patients within the global aHUS registry.全球非典型溶血尿毒综合征(aHUS)注册中心内英国患者的人口统计学和基线疾病特征。
BMC Nephrol. 2025 Aug 5;26(1):434. doi: 10.1186/s12882-025-04321-x.
2
Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review.溶血尿毒综合征的神经学表现:全面综述
Brain Sci. 2025 Jul 4;15(7):717. doi: 10.3390/brainsci15070717.
3
Ocular Manifestations in Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab: A Case Report and Review of the Literature.用ravulizumab治疗非典型溶血尿毒综合征的眼部表现:一例报告及文献综述
Cureus. 2025 May 17;17(5):e84271. doi: 10.7759/cureus.84271. eCollection 2025 May.
4
Comprehensive genetic analysis and genotype-phenotype correlations in pediatric patients with atypical hemolytic uremic syndrome.非典型溶血尿毒综合征儿科患者的综合基因分析及基因型-表型相关性研究
Pediatr Nephrol. 2025 Jun 6. doi: 10.1007/s00467-025-06814-1.
5
Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome.抗补体因子H抗体阳性与阴性非典型溶血性尿毒症综合征的长期预后
Indian J Nephrol. 2025 May-Jun;35(3):402-409. doi: 10.25259/IJN_106_2024. Epub 2024 Aug 14.
6
Atypical Hemolytic Uremic Syndrome: A Review of Complement Dysregulation, Genetic Susceptibility and Multiorgan Involvement.非典型溶血性尿毒症综合征:补体失调、遗传易感性及多器官受累综述
J Clin Med. 2025 Apr 7;14(7):2527. doi: 10.3390/jcm14072527.
7
Recommendations for diagnosis and treatment of Atypical Hemolytic Uremic Syndrome (aHUS): an expert consensus statement from the Rare Diseases Committee of the Brazilian Society of Nephrology (COMDORA-SBN).非典型溶血性尿毒症综合征(aHUS)的诊断与治疗建议:巴西肾脏病学会罕见病委员会(COMDORA - SBN)的专家共识声明
J Bras Nefrol. 2025 Apr-Jun;47(2):e20240087. doi: 10.1590/2175-8239-JBN-2024-0087en.
8
Complement-Mediated Hemolytic Uremic Syndrome Due to MCP/CD46 Mutation: A Case Report.由MCP/CD46突变引起的补体介导的溶血性尿毒症综合征:一例报告
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251316364. doi: 10.1177/23247096251316364.
9
Extrarenal manifestations of atypical hemolytic uremic syndrome: a systematic review and meta-analysis.非典型溶血尿毒综合征的肾外表现:一项系统综述和荟萃分析
Pediatr Res. 2024 Dec 15. doi: 10.1038/s41390-024-03771-7.
10
Atypical hemolytic uremic syndrome: diagnosis, management, and discontinuation of therapy.非典型溶血性尿毒症综合征:诊断、管理及治疗的终止
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):200-205. doi: 10.1182/hematology.2024000543.

本文引用的文献

1
Extra-Renal manifestations of atypical hemolytic uremic syndrome in children.儿童非典型溶血尿毒综合征的肾外表现。
Pediatr Nephrol. 2018 Aug;33(8):1395-1403. doi: 10.1007/s00467-018-3933-3. Epub 2018 Apr 2.
2
Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.因子 H 自身抗体与英国和爱尔兰儿童的非典型溶血性尿毒症综合征有关。
Kidney Int. 2017 Nov;92(5):1261-1271. doi: 10.1016/j.kint.2017.04.028. Epub 2017 Jul 24.
3
Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征继发的普-罗二氏样视网膜病变中,启动依库珠单抗治疗后威胁视力的失明情况得到逆转。
Int Ophthalmol. 2018 Feb;38(1):399-407. doi: 10.1007/s10792-017-0470-1. Epub 2017 Mar 8.
4
Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients.土耳其儿童非典型溶血尿毒综合征登记处:146例患者的初步分析
BMC Nephrol. 2017 Jan 5;18(1):6. doi: 10.1186/s12882-016-0420-6.
5
Hemolytic uremic syndrome in children.儿童溶血性尿毒症综合征
Minerva Pediatr. 2016 Dec;68(6):441-455.
6
The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome.补体替代途径与非典型溶血尿毒综合征不断演变的临床病理生理谱
Am J Med Sci. 2016 Aug;352(2):177-90. doi: 10.1016/j.amjms.2016.05.003. Epub 2016 May 9.
7
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.晚期及终末期肾病患者心血管疾病的诊断与管理
J Am Heart Assoc. 2016 Aug 4;5(8):e003648. doi: 10.1161/JAHA.116.003648.
8
Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab.用依库珠单抗治疗非典型溶血性尿毒症综合征和慢性溃疡性结肠炎。
Int J Med Pharm Case Reports. 2015;4(5):105-112. doi: 10.9734/IJMPCR/2015/18771. Epub 2015 Jun 19.
9
Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab.依库珠单抗治疗伴视网膜动静脉阻塞的非典型溶血性尿毒症综合征病例报告
Int Med Case Rep J. 2015 Oct 13;8:235-9. doi: 10.2147/IMCRJ.S90640. eCollection 2015.
10
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.使用补体抑制剂依库珠单抗治疗非典型溶血性尿毒症综合征:澳大利亚同情用药队列的经验
Intern Med J. 2015 Oct;45(10):1054-65. doi: 10.1111/imj.12864.

非肾性表现的非典型溶血尿毒综合征。

Extra-renal manifestations of atypical hemolytic uremic syndrome.

机构信息

Department of Nephrology, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

Pediatr Nephrol. 2019 Aug;34(8):1337-1348. doi: 10.1007/s00467-018-4039-7. Epub 2018 Aug 14.

DOI:10.1007/s00467-018-4039-7
PMID:30109445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8627279/
Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare and complex disease resulting from abnormal alternative complement activation with a wide range of clinical presentations. Extra-renal manifestations of aHUS can involve many organ systems, including the peripheral and central nervous, gastrointestinal, cardiovascular, integumentary, pulmonary, as well as the eye. While some of these extra-renal manifestations occur in the acute phase of aHUS, some can also occur as long-term sequelae of unopposed complement activation. Extra-renal symptoms are observed in approximately 20% of patients with aHUS, with the incidence of specific organ system complications ranging from a few case reports to 50% of described patients. Careful monitoring for extra-renal involvement is critical in patients with aHUS, as prompt evaluation and management may decrease the risk of high morbidity and mortality associated with aHUS.

摘要

非典型溶血尿毒综合征(aHUS)是一种罕见且复杂的疾病,由异常替代补体激活引起,临床表现多样。aHUS 的肾外表现可累及多个器官系统,包括外周和中枢神经系统、胃肠道、心血管系统、皮肤、肺以及眼睛。虽然这些肾外表现中的一些发生在 aHUS 的急性期,但也有一些可能是由于补体激活未被抑制而作为长期后遗症出现。大约 20%的 aHUS 患者存在肾外症状,特定器官系统并发症的发生率从少数病例报告到描述的患者的 50%不等。仔细监测 aHUS 患者的肾外表现至关重要,因为及时评估和管理可能会降低与 aHUS 相关的高发病率和死亡率的风险。